Insider · CIK 0001904824
Tod Smeal
Files at CRDF (Cardiff Oncology, Inc.). First filing -, latest -.
In brief
Tod Smeal files SEC Form 4 as officer at CRDF (Cardiff Oncology, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Tod Smeal has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 14, 2026 | CRDF Cardiff Oncology, Inc. | AGrant or award Stock Optionsderivative | +300,000 | $0.00 | $0 | 1,279,805 | Apr 16, 2026 |
| Mar 11, 2025 | CRDF Cardiff Oncology, Inc. | AGrant or award Stock Optionsderivative | +332,621 | $0.00 | $0 | 979,805 | Mar 13, 2025 |
Questions about Tod Smeal
Answered from the filings on this page, as of the latest one.
Is Tod Smeal buying or selling?
Tod Smeal has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Tod Smeal's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Tod Smeal has 0.
Where does Tod Smeal file Form 4?
Tod Smeal has filed Form 4 at CRDF (Cardiff Oncology, Inc.) as Chief Scientific Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.